In the context of DILI, one of the proposed mechanisms of the cholestasis is the competitive inhibition of SLCO1B1 and SLCO1B3 transporters by RIF, thereby impairing hepatic uptake of bilirubin—their endogenous substrate [61,64,65]. Here, SLCO1B1 is linked to cholestasis.